Biotech Innovations Made in Austria: Turning Bioprocess Innovation into Industrial Reality

Five Austrian innovators tackle one of the biggest hurdles in industrial biotech: making lab processes perform reliably, reproducibly, and economically at scale. VALIDOGEN shares "robust or bust" strategies for Pichia pastoris strain and process development, combining genetic engineering, modular expression solutions, and data-guided optimization for predictable large-scale protein production. Flecks Process Technology GmbH presents B.R.O.M.®, a scale-up approach that decouples process control and infrastructure from the vessel, ensuring consistent conditions from 30 to 20,000 L while reducing cost and time-to-market. BRAVE Analytics shows how single-particle Raman analytics moves from optofluidic physics into industrial bioprocesses for deeper insight and better control. Lanbiotic addresses translating microbiome-driven innovations into scalable, market-ready applications. GAMED demonstrates how contextualized process data turns complex automation signals into actionable information for operators, engineers, and production teams. Expect concrete lessons learned, technology insights, and an interactive discussion on bridging the gap between R&D success and industrial manufacturing.